Drug Database
Back to search

Denmark· DK-28103812205

Avaglim

A glimepiride and rosiglitazone product containing glimepirid, rosiglitazonmaleat, registered in Denmark by SmithKline Beecham plc. The same ATC class is registered in 2 of our 19 countries.

ATC A10BD04

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedAvaglimATCA10BD04REGISTER NO.DK-28103812205PACKS LISTED1CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about glimepirid, rosiglitazonmaleatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Glimepiride and rosiglitazone is registered in 2 of 19 countries.

Countries holding a registration under ATC A10BD04 (glimepiride and rosiglitazone), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 1 of them publish a price we can compare per daily dose
Search glimepiride and rosiglitazone products by name

Glimepiride and rosiglitazone · ATC A10BD04

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
GLIMEPIRID, ROSIGLITAZONMALEAT
Manufacturer
SmithKline Beecham plc
Country
Denmark (DK)
ATC code
A10BD04
ATC class
Glimepiride and rosiglitazone
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28103812205

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A10BD04

Glimepiride and rosiglitazone, as other registers publish it.

All glimepiride and rosiglitazone products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d2cbb043-95ae-441a-aede-992c5bbe04ca
GET /v1/drugs/d2cbb043-95ae-441a-aede-992c5bbe04ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "filmovertrukne tabletter",
  "source": "dkma",
  "strength": "8+4 mg",
  "auth_role": "MOD",
  "dk_drugid": "28103812205",
  "substance": "GLIMEPIRID, ROSIGLITAZONMALEAT",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "38895"
}
API referenceMCP serverPlans

See everything about glimepiride and rosiglitazone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console